These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33332457)

  • 1. Correction: The effects of locomotor activity on gastrointestinal symptoms of irritable bowel syndrome among younger people: An observational study.
    Hamaguchi T; Tayama J; Suzuki M; Nakaya N; Takizawa H; Koizumi K; Amano Y; Kanazawa M; Fukudo S
    PLoS One; 2020; 15(12):e0244465. PubMed ID: 33332457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of locomotor activity on gastrointestinal symptoms of irritable bowel syndrome among younger people: An observational study.
    Hamaguchi T; Tayama J; Suzuki M; Nakaya N; Takizawa H; Koizumi K; Amano Y; Kanazawa M; Fukudo S
    PLoS One; 2020; 15(5):e0234089. PubMed ID: 32470098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease.
    Kuo B; Bhasin M; Jacquart J; Scult MA; Slipp L; Riklin EI; Lepoutre V; Comosa N; Norton BA; Dassatti A; Rosenblum J; Thurler AH; Surjanhata BC; Hasheminejad NN; Kagan L; Slawsby E; Rao SR; Macklin EA; Fricchione GL; Benson H; Libermann TA; Korzenik J; Denninger JW
    PLoS One; 2017; 12(2):e0172872. PubMed ID: 28222181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Vitamin D status in pediatric irritable bowel syndrome.
    Nwosu BU; Maranda L; Candela N
    PLoS One; 2017; 12(3):e0173779. PubMed ID: 28278247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study.
    Weerts ZZRM; Heinen KGE; Masclee AAM; Quanjel ABA; Winkens B; Vork L; Rinkens PELM; Jonkers DMAE; Keszthelyi D
    JMIR Mhealth Uhealth; 2021 Feb; 9(2):e27998. PubMed ID: 33600349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and impact of irritable bowel syndrome in people with epilepsy.
    Camara-Lemarroy CR; Escobedo-Zúñiga N; Ortiz-Zacarias D; Peña-Avendaño J; Villarreal-Garza E; Díaz-Torres MA
    Epilepsy Behav; 2016 Oct; 63():29-33. PubMed ID: 27552483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Should All Women with Polycystic Ovary Syndrome Be Screened for Metabolic Parameters?: A Hospital-Based Observational Study.
    Li H; Li L; Gu J; Li Y; Chen X; Yang D
    PLoS One; 2017; 12(4):e0176806. PubMed ID: 28445552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Heart rate variability helps to distinguish the intensity of menopausal symptoms: A prospective, observational and transversal study.
    Martinelli PM; Sorpreso ICE; Raimundo RD; Junior OSL; Zangirolami-Raimundo J; Malveira de Lima MV; Pérez-Riera A; Pereira VX; Elmusharaf K; Valenti VE; de Abreu LC
    PLoS One; 2020; 15(2):e0229094. PubMed ID: 32027729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Correction: Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma.
    Ye X; Zhang G; Chen H; Li Y
    PLoS One; 2018; 13(12):e0209868. PubMed ID: 30571756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review: serotonergic modulators in the treatment of irritable bowel syndrome--influence on psychiatric and gastrointestinal symptoms.
    Kilkens TO; Honig A; Rozendaal N; Van Nieuwenhoven MA; Brummer RJ
    Aliment Pharmacol Ther; 2003 Jan; 17(1):43-51. PubMed ID: 12492731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TPH1 rs211105 gene polymorphism affects abdominal symptoms and quality of life of diarrhea-predominant irritable bowel syndrome.
    Katsumata R; Shiotani A; Murao T; Ishii M; Fujita M; Matsumoto H; Haruma K
    J Clin Biochem Nutr; 2018 May; 62(3):270-276. PubMed ID: 29892168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index.
    Labus JS; Mayer EA; Chang L; Bolus R; Naliboff BD
    Psychosom Med; 2007 Jan; 69(1):89-98. PubMed ID: 17244851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
    PLOS ONE Staff
    PLoS One; 2017; 12(2):e0170865. PubMed ID: 28152078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.
    Waljee AK; Wiitala WL; Govani S; Stidham R; Saini S; Hou J; Feagins LA; Khan N; Good CB; Vijan S; Higgins PDR
    PLoS One; 2018; 13(5):e0197341. PubMed ID: 29742165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of the Manning criteria in irritable bowel syndrome.
    Talley NJ; Phillips SF; Melton LJ; Mulvihill C; Wiltgen C; Zinsmeister AR
    Gut; 1990 Jan; 31(1):77-81. PubMed ID: 2318433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma.
    Ye X; Zhang G; Chen H; Li Y
    PLoS One; 2018; 13(11):e0207816. PubMed ID: 30440028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Random-Effects, Fixed-Effects and the within-between Specification for Clustered Data in Observational Health Studies: A Simulation Study.
    Dieleman JL; Templin T
    PLoS One; 2016; 11(5):e0156508. PubMed ID: 27218254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease.
    Kamm F; Strauch U; Degenhardt F; Lopez R; Kunst C; Rogler G; Franke A; Klebl F; Rieder F
    PLoS One; 2018; 13(9):e0203709. PubMed ID: 30180207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.
    Williams AD; Korolkova OY; Sakwe AM; Geiger TM; James SD; Muldoon RL; Herline AJ; Goodwin JS; Izban MG; Washington MK; Smoot DT; Ballard BR; Gazouli M; M'Koma AE
    PLoS One; 2017; 12(12):e0189551. PubMed ID: 29211779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic review: Natural history of irritable bowel syndrome.
    El-Serag HB; Pilgrim P; Schoenfeld P
    Aliment Pharmacol Ther; 2004 Apr; 19(8):861-70. PubMed ID: 15080847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.